Tag: Insilico

Medicine

Insilico Medicine expands synthetic lethality

11 months ago
Dr. Jane

New York, May 5, 2022 /PRNewswire/ — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has nominated a preclinical candidate (PCC)…

Medicine

Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers

11 months ago
Dr. Jane

NEW YORK, May 5, 2022 /PRNewswire/ — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has nominated a preclinical candidate (PCC)…

Medicine

Insilico Medicine expands synthetic lethality portfolio with the nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers

11 months ago
Dr. Jane

NEW YORK, May 6, 2022 /PRNewswire/ — Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has nominated a preclinical candidate (PCC)…

Medicine

A.I. drug discovery platform Insilico Medicine announces $255 million in Series C funding – TechCrunch

2 years ago
Dr. Jane

Insilico Medicine, an AI-based drug development and discovery platform, announced Tuesday Series C funding of $ 255 million. The massive round reflects a recent breakthrough for the company: proof that…